An anti-aggregant tau mouse model shows increased neurogenesis and hippocampal volume [120], whilst tauopathy models frequently show deficits in hippocampal neurogenesis [134], potentially highlighting tau aggregation as a loss-of-function mechanism in this context. The gene discussed is MAPT; the disease is tauopathy.